NBN, RAD51 and XRCC3 Polymorphisms as Potential Predictive Biomarkers of Adjuvant Radiotherapy Toxicity in Early HER2-Positive Breast Cancer

SIMPLE SUMMARY: Adjuvant radiotherapy for breast cancer patients significantly improves survival and causes side effects. It is known that the response to radiotherapy is individual, but we are not yet able to predict patients with high risk for acute or late radiotherapy adverse events. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Goričar, Katja, Dugar, Franja, Dolžan, Vita, Marinko, Tanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496855/
https://www.ncbi.nlm.nih.gov/pubmed/36139526
http://dx.doi.org/10.3390/cancers14184365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496855/
https://www.ncbi.nlm.nih.gov/pubmed/36139526
http://dx.doi.org/10.3390/cancers14184365

Ejemplares similares